Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 417 (OTC: $CSUI)
(NYSE: $ACB) (TSX: $ACB.TO) (CSE:
$CURA.C) (TSXV: $RTI.V)
Delta, Kelowna, BC, May 21, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/05211CSUI-ACB-CURA-RTI.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
Today’s
podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research &
development company licensed under Swiss Cannabis and tobacco regulations to
cultivate and sell cannabis. The Company's facilities for producing cannabis
are based in Zurich.
The
Company grows high quality, organic cannabis with sustainable, all-natural
principles. Cannabis Suisse products are laboratory tested to ensure the end
users have access to a standardized, safe and consistent product.
In
today’s podcast we will be looking at a few public company announcements.
Cannabis Suisse
Corp.
(OTC:
CSUI), being a fully licensed Swiss cannabis cultivation
and distribution company for recreational tobacco products and medical CBD
oils, announced that it
has signed a distribution agreement with Hanfpost GmbH, one of Swiss leading
online sellers of cannabis products.
The
two-year agreement is aimed at building a long-term partnership. The cooperation is expected to bring
continuous stable revenue from a wide selection of Cannabis Suisse' product
lines, marketed under the Alpine Cannabis brand. These include premium smoking
weed, pre-rolled joints, CBD oils and pure base liquid hemp.
Under
the terms of this agreement, Cannabis Suisse becomes one of the suppliers of
Hanfpost GmbH. Cannabis Suisse intends to provide the best quality for the
lowest price, so the Company hopes to occupy a huge part of Hanfpost website.
The
partnership between two companies is not only based on financial targets but is
also believed to build solid trust in Cannabis Suisse' consistent and
sustainable quality and dedication to bringing premium products to the Swiss
home market. Switzerland has the highest allowed legislative THC content in
Europe (1%) for sales of cannabis products in retail outlets (without medical
receipt). This makes Switzerland a perfect geographic location to manufacture
cannabis products, with the intent to scale the business into worldwide
distribution. The Company will be provided with the platform to establish new
business relationships, make Alpine Cannabis trademark recognizable, bring its
high-quality CBD products to broader range of consumers, present the product in
the growing market. Cannabis Suisse Corp. intends to become a leader in the
Swiss CBD market. The Company hopes to quickly expand its customer base in
neighboring countries as well.
The
choice of Hanfpost GmbH for a strategic partnership is not random. Among other
advantages of this internet distributor there is an opportunity to create a
customer account, a list of wishes and selected products, a wide assortment of
goods for wholesale and retail purchase, round-the-clock work, useful and
relevant information about CBD products, latest industry news, free delivery
from 99 CHF or the takeaway store in Grenchen.
All
the products represented on the website are made with great love and experience
exclusively in Switzerland. Hanfpost suppliers specialize in the production of
cannabis products with a THC level below 1%, completely abandoning fungicides
and herbicides. All the goods are subject to stringent quality controls,
everything is checked by the accredited laboratories and registered with the
Federal Health Office, meaning it is 100% compliant with Swiss legislation.
Due
to a proven track record, deep knowledge of the local market and a leading
distribution platform in Switzerland, Hanfpost is an excellent partner for
strategic access to a strong and fast-growing cannabis market with a long-term
growth potential.
The
agreement allows Cannabis Suisse Corp. to increase the potential for additional
income and expand the company's operations without increasing expenses. Such
cooperation involves additional income not only of the Company, but also of its
shareholders, as it strengthens the CSUI market position.
Aurora
Cannabis Inc. (NYSE:
ACB)
(TSX:
ACB),
the Canadian company defining the future of cannabinoids worldwide, and Reliva,
LLC a leader in the sale of hemp-derived CBD products in the United States, announced that they
have entered into an agreement pursuant
to which Aurora will acquire all of the issued and outstanding membership
interests of Reliva. Under the terms of the agreement, members of Reliva will
receive approximately US$40 million of Aurora common shares. The transaction also includes a potential
earn-out of up to a maximum of US$45 million payable in Aurora shares, cash or
a combination thereof, over the next two years contingent upon Reliva achieving
certain financial targets.
The structure of
the earn-out is designed to align risk and reward between Aurora shareholders
and Reliva management to focus on continued strong operational and financial
execution. The transaction is expected to close, subject to customary closing
conditions, in June 2020 . It is anticipated that the transaction will be
immediately accretive to Aurora on an Adjusted EBITDA basis, consistent with
Aurora's objective to drive towards Adjusted EBITDA profitability in its fiscal
first quarter of 2021.
The transaction
will combine Aurora's leading Canadian recreational brands, and Canadian and
European medical market position with the leading U.S. hemp-derived CBD brand
in retail stores. Consistent with the announcement of Aurora's business
transformation plan in February 2020 , the Company has aligned its U.S.
investment strategy with the goals of the transformation plan, namely:
financial discipline, operational focus, and strong execution.
The transaction
represents the culmination of a multi-month strategic evaluation of the U.S. hemp-derived
CBD industry. Reliva stood out among a lengthy list of potential partners for
its: (1) focus on regulatory, testing and compliance protocols; (2) proven
management team with extensive experience selling and marketing regulated
consumer packaged goods; (3) deep relationships with critical trade partners
that provide a U.S. national distribution footprint; and (4) financial
discipline and track record of growth and profitability. Together with Reliva,
Aurora is expected to be positioned as a meaningful player in the United States
, the world's largest cannabinoid market.
"Together,
Aurora and Reliva will partner to create an international cannabinoid leader
that we believe can deliver robust revenue and profitable growth," said
Michael Singer , Executive Chairman and Interim CEO of Aurora. "We have
taken the time necessary to carefully assess the Company's entry into the U.S.
market and we firmly believe that the combination with Reliva will create
significant long-term value as Reliva provides us options to grow in
hemp-derived CBD internationally. Similar to Aurora, Reliva has a strong
entrepreneurial spirit and successful track record of transforming categories
and creating growth brands. We welcome Miguel Martin and his team to Aurora,
and look forward to the opportunity to increase our operating scale,
international reach, and product and brand diversity as we drive to Adjusted
EBITDA profitability. We plan to capitalize on each company's market leadership
and sales infrastructure to drive higher revenue growth than either company
could independently accomplish."
Curaleaf Holdings,
Inc. (CSE:
CURA) (OTCQX:
CURLF), a leading vertically integrated cannabis operator in
the United States, today
announced that retail locations in Massachusetts will re-open
for adult-use purchases starting on May 25th, 2020.
Dispensary
locations in Ware and Oxford will be open for regular hours from 9 AM to 8 PM
Monday through Saturday, and 10 AM to 5 PM Sunday. The Provincetown location
will be open for new summer hours from 9 AM to 9 PM Monday through Sunday.
"We
are pleased that our three adult use dispensaries in Ware, Oxford and
Provincetown are among the first of Commonwealth businesses allowed to re-open
on May 25, and we appreciate the Governor and Lt. Governor's decision,"
said Patrik Jonsson, president of Curaleaf Massachusetts. "We're very much
looking forward to resuming serving our customers with the quality products
they have come to rely on, and also getting our people back to work. We expect
sales to be brisk as a result of pent up demand, and we are working closely
with the Cannabis Control Commission and the Massachusetts Department of Health
to comply with all guidelines surrounding our reopening."
Curaleaf's
employees will continue to exercise all appropriate measures to ensure the
safety of their customers and staff. This includes enforcement of social
distancing, mandatory face masks for all employees and customers, increased
sanitation and hygiene measures, and the use of technology to minimize contact
during the purchasing process as well as other day-to-day store operations.
Radient
Technologies Inc. (TSXV:
RTI)
(OTCQX:
RDDTF), a global manufacturer of high quality
cannabinoid-based ingredients, formulations and products, announced the
launch of bioU, a scientifically
formulated brand exclusively sold to Medical Cannabis by Shoppers™, a
subsidiary of Shoppers Drug Mart Inc., and available across Canada.
Radient’s
first products released under the bioU label will be the Uspray series of high
quality, scientifically formulated oral cannabis sprays. bioU
Uspray will have three formulations available to consumers on the Medical
Cannabis by Shoppers online platform; a THC dominant formula with 30mg/mL of
THC and 1 mg/mL of CBD, a CBD dominant formula with 20 mg/mL CBD and 1 mg/mL
THC, and a balanced formula with 10 mg/mL THC and 10 mg/mL CBD. All bioU products have been designed by
Radient to retain cannabinoids and terpenes while providing high levels of
purity and consistency.
“We
are very excited to launch this line of products with Medical Cannabis by
Shoppers. This is a key step for the
Company in forging a long-term and successful partnership with one of Canada’s
most trusted names in retail. We look
forward to broadening our product offering with Shoppers and giving consumers
access to the first branded products from Radient,” said Denis Taschuk, Chief
Executive Officer, Radient Technologies.
Radient
plans on expanding the products available under the bioU brand over the coming
months. The bioU brand will use
Radient’s proprietary broad spectrum cannabinoid extracts along with an
extensive library of internally developed formulations. Radient’s unique, continuous-flow extraction
process has been proven to achieve a higher recovery of active compounds from
the cannabis plant (up to 99%) than other extraction methods. It has lower risk
of cannabinoid degradation during processing which allows products to maintain
shelf life for a longer period of time, and has a high level of product
consistency. Combining its unique extraction technology with stringent quality
control systems and decades of botanical ingredient manufacturing experience,
Radient produces a variety of broad spectrum cannabinoid formulations,
ingredients and products that meet the highest standards of quality and safety.
Once
again, today’s podcast was sponsored by Cannabis Suisse Corp. (OTC: CSUI), a
research & development company licensed under Swiss Cannabis and tobacco
regulations to cultivate and sell cannabis. The Company's facilities for
producing cannabis are based in Zurich.
The
Company grows high quality, organic cannabis with sustainable, all-natural
principles. Cannabis Suisse products are laboratory tested to ensure the end
users have access to a standardized, safe and consistent product.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. Disclosure: CSUI is a paid month news and social media
cannabis stock . More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to
regulations of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
